Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Preparation and Use of Certified Reference Standards – V 2.0

Posted on By

Analytical Method Development: SOP for Preparation and Use of Certified Reference Standards – V 2.0

Standard Operating Procedure for Preparation and Use of Certified Reference Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/379/2025
Supersedes SOP/AMD/379/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2027

1. Purpose

This SOP defines the procedure for the qualification, documentation, preparation, and utilization of Certified Reference Standards (CRS) within the Analytical Method Development (AMD)

department. Proper use of CRS ensures accuracy, traceability, and regulatory compliance of analytical test results.

2. Scope

This procedure is applicable to all activities involving the use of certified reference standards in AMD for chromatographic and spectroscopic techniques, including HPLC, GC, UV, and LC-MS, across pharmaceutical development processes.

3. Responsibilities

  • Analyst: Handles CRS preparation, documentation, and usage as per protocol.
  • AMD Coordinator: Maintains CRS inventory and coordinates qualification processes.
  • QA Representative: Reviews CRS documentation and ensures GMP-compliance during usage and documentation.
See also  Analytical Method Development: Complexometric Titration Method Development - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that certified reference standards are procured, stored, and used in accordance with regulatory requirements and this SOP.

5. Procedure

5.1 Procurement and Receipt

  1. Procure certified reference standards from approved vendors or pharmacopoeial sources (e.g., USP, EP, BP).
  2. Ensure each CRS is accompanied by a Certificate of Analysis (CoA), traceability certificate, and shipping label.
  3. Inspect packaging for integrity and verify label details (batch number, purity, expiry, storage conditions).
  4. Record receipt in CRS logbook (Annexure-1) and assign CRS ID number.

5.2 Storage Conditions

  1. Store CRS under recommended conditions as per supplier’s CoA (e.g., 2–8°C, -20°C, desiccator).
  2. Segregate CRS from working standards and retain in a secure, restricted-access cabinet.
  3. Monitor temperature logs daily using calibrated data loggers.

5.3 Qualification of CRS

  1. Review CoA for analytical data such as:
    • Assay value and uncertainty
    • Water content
    • Residual solvents
    • Traceability to SI units or national standards
  2. Document qualification summary in Annexure-2 template and obtain QA approval before use.

5.4 Preparation of CRS Solutions

  1. Calculate quantity based on labeled purity (on anhydrous or as-is basis).
  2. Use calibrated balance and Class A volumetric equipment.
  3. Record preparation details: analyst name, date, solvent, CRS lot number, and concentration.
  4. Label solution with:
    • CRS ID
    • Date of preparation
    • Concentration
    • Expiry date (based on stability data or default 1 month)
See also  Analytical Method Development: SOP for Dissolution Method for Delayed Release Tablets - V 2.0

5.5 Usage and Traceability

  1. Document CRS use in the test method logbook or worksheet with CRS ID and quantity used.
  2. Maintain a chain-of-custody record for each use or withdrawal.
  3. Ensure CRS is not used beyond expiry or requalification date.

5.6 Disposal of Expired or Unused CRS

  1. Mark “EXPIRED” on label and segregate CRS containers for destruction.
  2. Follow hazardous waste disposal protocols per site SOPs.
  3. Update CRS logbook with disposal date, reason, and authorized personnel signature.

5.7 Handling Deviations

  1. Log deviations related to CRS purity mismatch, improper labeling, or out-of-spec assay.
  2. Conduct Root Cause Analysis (RCA) and initiate Corrective and Preventive Action (CAPA).
  3. Record deviation closure details in Annexure-3.

6. Abbreviations

  • CRS: Certified Reference Standard
  • CoA: Certificate of Analysis
  • RCA: Root Cause Analysis
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Annexure-1: CRS Inventory Logbook
  2. Annexure-2: Qualification Summary Template
  3. Annexure-3: CRS Deviation Report
See also  Analytical Method Development: SOP for End Point Determination in Granulation via NIR - V 2.0

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • USP General Chapter <11> – Reference Standards
  • WHO TRS 996 – Annex 6

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Dr. Rachana Mehta Amit Kapoor Dr. Krishnan Iyer
Designation Analytical Chemist QA Reviewer Department Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: CRS Inventory Logbook

CRS ID Substance Name Lot No. Received Date Expiry Date Storage Condition
CRS-2025-01 Paracetamol PA12458 01/05/2025 01/05/2027 2–8°C

Annexure-2: Qualification Summary Template

Details to include: supplier name, CoA verification, purity value, water content, residual solvents, stability summary, and QA approval.

Annexure-3: CRS Deviation Report

Deviation ID Description RCA CAPA Status
CRS-DEV-01 Label mismatch on received standard Supplier error Vendor notification and corrected labels Closed

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Updated preparation and qualification steps Annual SOP Review Dr. Krishnan Iyer
15/07/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Estimating Detection Limit Using Slope and SD Method – V 2.0
Next Post: Analytical Method Development: SOP for Stability-Indicating Method Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version